Baseline demographics and intensity of pain at follow up I and II
| Baseline variable | All (n = 297) | Follow up I | Follow up II | ||
|---|---|---|---|---|---|
| No or mild pain (n = 201) | Moderate to severe pain (n = 96) | No or mild pain (n = 235) | Moderate to severe pain (n = 62) | ||
| *Significant differences between the groups with no to mild and moderate to severe pain. | |||||
| †Diagnoses in the table are defined in the Methods section. | |||||
| CI, cerebral infarction; HbA1c, glycosylated haemoglobin; ICH, intracerebral haemorrhage; NIHSS, National Institutes of Health stroke scale; SAH, subarachnoid haemorrhage; UND, undefined. | |||||
| Male | 60% | 64% | 52%*(p = 0.047) | 63% | 52% |
| Age (years) (mean) | 72.1 | 72.5 | 71.3 | 72.4 | 71.0 |
| Male | 70.5 | 70.7 | 70.0 | 70.6 | 69.9 |
| Female | 74.6 | 75.8 | 72.7 | 75.4 | 72.2 |
| Age range (years) | 17 to 96 | 17 to 96 | 45 to 95 | 17 to 95 | 45 to 96 |
| Hypertension† | 54% | 55% | 52% | 55% | 50% |
| Diabetes mellitus† | 14% | 12% | 18% | 13% | 18% |
| Cardiac disease† | 37% | 36% | 41% | 35% | 45% |
| Main type of stroke | |||||
| CI | 89.2% | 89.1% | 89.6% | 89.4% | 88.7% |
| ICH | 6.4% | 8.0% | 3.1% | 6.4% | 6.5% |
| SAH | 4.0% | 3.0% | 6.3% | 4.3% | 3.2% |
| UND | 0.3% | – | 1.0% | – | 1.6% |
| NIHSS (mean score) | 5.0 | 4.2 | 6.6 | 4.9 | 5.2 |
| Sensory disturbance | 27% | 22% | 39%*(p = 0.003) | 26% | 31% |
| HbA1c >5.3 per cent | 17% | 14% | 24%*(p = 0.015) | 15% | 27% |